LipoAerosol© Inhalation After Tracheostomy
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
Inclusion Criteria
- Patients ≤24h after tracheostomy and regular patient's consent
- Patients ≤24h after tracheostomy and regular patient's consent
Exclusion Criteria
- Patients with chronic respiratory insufficiency
- Patients with existing bronchopulmonary inflammation
- Patients >24h after tracheostomy
- ...
- Patients with chronic respiratory insufficiency
- Patients with existing bronchopulmonary inflammation
- Patients >24h after tracheostomy
- No regular patient's consent
- Known allergy for ingredients
- Patients with poorly adjusted pulmonary disease
- Patients with immunosuppressive therapy
- Patients with acute or imminent sepsis
Summary
- Conditions
- Other Tracheostomy Complication
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Supportive Care
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Inclusion Criteria
- Patients ≤24h after tracheostomy and regular patient's consent
- Patients ≤24h after tracheostomy and regular patient's consent
Exclusion Criteria
- Patients with chronic respiratory insufficiency
- Patients with existing bronchopulmonary inflammation
- Patients >24h after tracheostomy
- ...
- Patients with chronic respiratory insufficiency
- Patients with existing bronchopulmonary inflammation
- Patients >24h after tracheostomy
- No regular patient's consent
- Known allergy for ingredients
- Patients with poorly adjusted pulmonary disease
- Patients with immunosuppressive therapy
- Patients with acute or imminent sepsis
Tracking Information
- NCT #
- NCT02157129
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Andreas Knopf, PD Dr. HNO, Klinikum rechts der Isar, TU München
- Andreas Knopf, PD Dr. HNO, Klinikum rechts der Isar, TU München
Get Well Soon